These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 17056936)
1. Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes. Royston D; Levy JH; Fitch J; Dietrich W; Body SC; Murkin JM; Spiess BD; Nadel A Anesth Analg; 2006 Nov; 103(5):1082-8. PubMed ID: 17056936 [TBL] [Abstract][Full Text] [Related]
2. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials. Smith PK; Datta SK; Muhlbaier LH; Samsa G; Nadel A; Lipscomb J Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451 [TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201 [TBL] [Abstract][Full Text] [Related]
4. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting. Lindvall G; Sartipy U; van der Linden J Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456 [TBL] [Abstract][Full Text] [Related]
5. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial. Greilich PE; Jessen ME; Satyanarayana N; Whitten CW; Nuttall GA; Beckham JM; Wall MH; Butterworth JF Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691 [TBL] [Abstract][Full Text] [Related]
6. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. van der Linden J; Lindvall G; Sartipy U Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831 [TBL] [Abstract][Full Text] [Related]
7. Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study. Øvrum E; Tangen G; Tølløfsrud S; Ringdal MA; Øystese R; Istad R Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):545-8. PubMed ID: 20067988 [TBL] [Abstract][Full Text] [Related]
8. Perioperative statin therapy is associated with a significant and dose-dependent reduction of adverse cardiovascular outcomes after coronary artery bypass graft surgery. Ouattara A; Benhaoua H; Le Manach Y; Mabrouk-Zerguini N; Itani O; Osman A; Landi M; Riou B; Coriat P J Cardiothorac Vasc Anesth; 2009 Oct; 23(5):633-8. PubMed ID: 19362495 [TBL] [Abstract][Full Text] [Related]
9. Aprotinin is not associated with postoperative renal impairment after primary coronary surgery. Lindvall G; Sartipy U; Ivert T; van der Linden J Ann Thorac Surg; 2008 Jul; 86(1):13-9. PubMed ID: 18573391 [TBL] [Abstract][Full Text] [Related]
10. Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery. Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Hu S Ann Thorac Surg; 2010 May; 89(5):1489-95. PubMed ID: 20417766 [TBL] [Abstract][Full Text] [Related]
11. Aprotinin decreases the incidence of cognitive deficit following CABG and cardiopulmonary bypass: a pilot randomized controlled study. Harmon DC; Ghori KG; Eustace NP; O'Callaghan SJ; O'Donnell AP; Shorten GD Can J Anaesth; 2004 Dec; 51(10):1002-9. PubMed ID: 15574551 [TBL] [Abstract][Full Text] [Related]
12. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study. Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159 [TBL] [Abstract][Full Text] [Related]
15. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss. Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135 [TBL] [Abstract][Full Text] [Related]
16. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Spiess BD; Royston D; Levy JH; Fitch J; Dietrich W; Body S; Murkin J; Nadel A Transfusion; 2004 Aug; 44(8):1143-8. PubMed ID: 15265117 [TBL] [Abstract][Full Text] [Related]
17. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting. Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345 [TBL] [Abstract][Full Text] [Related]
18. Effects of minimal dose aprotinin on blood loss and fibrinolytic system-complement activation in coronary artery bypass grafting surgery. Cicekcioglu F; Cagli K; Emir M; Topbas M; Catav Z; Sener E; Tasdemir O J Card Surg; 2006; 21(4):336-41. PubMed ID: 16846409 [TBL] [Abstract][Full Text] [Related]
19. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Guru V; Omura J; Alghamdi AA; Weisel R; Fremes SE Circulation; 2006 Jul; 114(1 Suppl):I331-8. PubMed ID: 16820596 [TBL] [Abstract][Full Text] [Related]
20. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery. Khalil PN; Siebeck M; Ismail M; Khalil MN; von Knobelsdorff G; Marx G; Kalmar P Eur J Med Res; 2006 Sep; 11(9):386-93. PubMed ID: 17101462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]